posted on 2025-02-06, 17:50authored byMohamed AliMohamed Ali, Emily M. Limerick, Matthew M. Hsieh, Kalpana Upadhyaya, Xin Xu, Oswald Phang, Jean Pierre Kambala Mukendi, Katherine R. Calvo, Maria Lopez-Ocasio, Pradeep Dagur, Courtney D. Fitzhugh
We performed chimerism analyses of 5 SCD patients who developed hematologic malignancies after non-myeloablative allogenic hematopoietic cell transplant. Sorted peripheral blood or bone marrow cells representing mature cell lineages or leukemic blasts were collected, DNA was extracted, and chimerism analysis was done by PCR amplification of polymorphic short tandem repeats.
Funding
Intramural Research Program of the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health and the Cooperative Study of Late Effects for SCD Curative Therapies (COALESCE, 1U01HL156620-01, NHLBI).